Ajanta Pharma Limited (AJANTPHARM) Share Analysis
NSE · Healthcare · Pharmaceuticals
Ajanta Pharma Limited (NSE: AJANTPHARM) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400. As of 14 Nov 2026, the share price was ₹3,284.00, P/E 32.5, ROE 27.1%.
Get the AI verdict on AJANTPHARM: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
AJANTPHARM chart with trendlines
Is AJANTPHARM a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Ajanta Pharma Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
AJANTPHARM key facts
| Price and valuation | |
|---|---|
| Share price | ₹3,284.00 |
| Market cap | ₹41,037 Cr |
| P/E ratio | 32.5 |
| P/B ratio | 8.44 |
| EPS | ₹101.07 |
| Book value per share | ₹389.00 |
| Dividend yield | 0.97% |
| 52-week range | |
| 52-week high | ₹3,796.00 |
| 52-week low | ₹2,445.80 |
| Face value | ₹2.00 |
| Shareholding pattern | |
| Promoters | 63.47% |
| FIIs | 7.62% |
| DIIs | 21.94% |
| Public | 6.96% |
Index membership: NIFTY 500, NIFTY Midcap 150, NIFTY MidSmallcap 400, NIFTY Pharma.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.